The Valley Desk

NCT05658510 · Interventional trial

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

Overall registry status Completed

Phase 3

Conditions Agitation,Psychomotor, Bipolar I Disorder, Bipolar II Disorder, Schizoaffective Disorder, Schizophrenia, Schizophreniform Disorders

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov